| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |